Page 1 | Search Results | Blood | American Society of Hematology

1-9 of 9

Sort by

Sort Order Select

Journal Articles

Effective Prevention of Acute and Chronic Graft-Versus-Host Disease with Anti-Lymphocyte Globulin (ATG) without Increase of Relapse in HLA-Identical Sibling Peripheral Blood Stem Cell Transplantation.

Nicolaus Kröger, Tatjana Zabelina, Francis Ayuk, Haefaa Alchalby, MD, Christine Wolschke, Thomas Stübig, Evgeny Klyuchnikov, Jürgen Berger, Axel R. Zander, MD

Blood (2012) 120 (21): 3055.

https://doi.org/10.1182/blood.V120.21.3055.3055

Published: 2012

Journal Articles

Donor Choice for Allogeneic Stem Cell Transplantation for AML – A Retrospective Single Centre Long-Term Analysis,

Francis Ayuk, MD, Friedericke Bernhardt, MD, Tatjana Zabelina, MD, Thomas Stübig, MD, Haefaa Alchalby, MD, Christine Wolschke, MD, Heinrich Lellek, MD, Ulrike Bacher, MD, Axel R. Zander, MD, Nicolaus Kröger

Blood (2011) 118 (21): 4147.

https://doi.org/10.1182/blood.V118.21.4147.4147

Published: 2011

Journal Articles

Lenalidomide Maintenance Therapy After Toxicity-Reduced Myeloablative Allograft As Salvage Therapy for Efractory/Relapsed Myeloma Patients

Nicolaus Kröger, Evgeny Klyuchnikov, MD, Thomas Stübig, MD, Christine Wolschke, MD, Francis Ayuk, MD, Tatjana Zabelina, MD, York Hildebrandt, Ulrike Bacher, MD, Anita Badbaran, Georgia Schilling, MD, Orhan Sezer, MD, PhD, Djordje Atanackovic, M.D., Martin Kropff, MD, Axel R. Zander, MD

Blood (2011) 118 (21): 3024.

https://doi.org/10.1182/blood.V118.21.3024.3024

Published: 2011

Journal Articles

Achievement of Sustained Molecular Remission Induces Long-Term Freedom From Disease After Autologous-Allogeneic Tandem Transplantation in Patients with Multiple Myeloma

Nicolaus Kröger, Tatjana Zabelina, MD, Francis Ayuk, MD, Christine Wolschke, MD, Haefaa Alchalby, Anita Badbaran, Djordje Atanackovic, M.D., Georgia Schilling, MD, Orhan Sezer, MD, PhD, Ulrike Bacher, MD, Thomas Stübig, MD, Boris Fehse, Ph.D., Axel R. Zander, MD

Blood (2011) 118 (21): 148.

https://doi.org/10.1182/blood.V118.21.148.148

Published: 2011

Journal Articles

Introduction of Differential KIR Activation Mediated Patters of NK Cell Cytotoxicity Against Myeloma

Thomas StÜbig, York Hildebrand, Karla Jungk, Aga Konielsk, Lars Lange, Thomas Binder, Heidi Duske, Djordje Atanackovic, Boris Fehse, Thomas Eiermann, Axel R. Zander, MD, Nicolaus Kröger, MD

Blood (2010) 116 (21): 5178.

https://doi.org/10.1182/blood.V116.21.5178.5178

Published: 2010

Journal Articles

Donor KIR-Haplotype B Improved Relapse-Free Survival After Allogeneic Stem Cell Transplantation for Multiple Myeloma

Nicolaus Kröger, Heidi Duske, Tatjana Zabelina, Thomas Binder, Boris Fehse, Orhan Sezer, MD, PhD, Thomas Stübig, York Hildebrandt, Djordje Atanackovic, Axel R. Zander, MD, Thomas Eiermann

Blood (2010) 116 (21): 2373.

https://doi.org/10.1182/blood.V116.21.2373.2373

Published: 2010

Journal Articles

Dose Finding Study of Lenalidomide as Maintenance Therapy In Multiple Myeloma After Allogeneic Stem Cell Transplantation

Christine Wolschke, Stefan O Schonland, Ute Hegenbart, Thomas Stübig, Marion Heinzelmann, York Hildebrandt, Michael Lioznov, Axel R. Zander, MD, Nicolaus Kröger, MD

Blood (2010) 116 (21): 2376.

https://doi.org/10.1182/blood.V116.21.2376.2376

Published: 2010

Journal Articles

Related Vs Unrelated Donors After Auto-Allo Tandem Stem Cell Transplantation for Newly Diagnosed Patients with Multiple Myeloma.

Nicolaus Kröger, MD, Tatjana Zabelina, Marion Heinzelmann, Georgia Schilling, Christine Wolschke, Heinrich Lellek, Thomas Stübig, Maite Lestin, Haefaa Alchalby, Francis Ayuk, Djordje Atanackovic, M.D., Ulrike Bacher, Boris Fehse, Axel R. Zander

Blood (2009) 114 (22): 1201.

https://doi.org/10.1182/blood.V114.22.1201.1201

Published: 2009

Journal Articles

Induction Chemotherapy Followed Immediately by Busulfan-Based Reduced Conditioning and Allografting in Elderly Patients with Advanced MDS or sAML.

Nicolaus Kröger, MD, Tatjana Zabelina, Christine Wolschke, Heinrich Lellek, Thomas Stübig, Maite Lestin, Haefaa Alchalby, Francis Ayuk, Ulrike Bacher, Boris Fehse, Axel R. Zander

Blood (2009) 114 (22): 3387.

https://doi.org/10.1182/blood.V114.22.3387.3387

Published: 2009

NARROW

Effective Prevention of Acute and Chronic Graft-Versus-Host Disease with Anti-Lymphocyte Globulin (ATG) without Increase of Relapse in HLA-Identical Sibling Peripheral Blood Stem Cell Transplantation.

Donor Choice for Allogeneic Stem Cell Transplantation for AML – A Retrospective Single Centre Long-Term Analysis,

Lenalidomide Maintenance Therapy After Toxicity-Reduced Myeloablative Allograft As Salvage Therapy for Efractory/Relapsed Myeloma Patients

Achievement of Sustained Molecular Remission Induces Long-Term Freedom From Disease After Autologous-Allogeneic Tandem Transplantation in Patients with Multiple Myeloma

Introduction of Differential KIR Activation Mediated Patters of NK Cell Cytotoxicity Against Myeloma

Donor KIR-Haplotype B Improved Relapse-Free Survival After Allogeneic Stem Cell Transplantation for Multiple Myeloma

Dose Finding Study of Lenalidomide as Maintenance Therapy In Multiple Myeloma After Allogeneic Stem Cell Transplantation

Related Vs Unrelated Donors After Auto-Allo Tandem Stem Cell Transplantation for Newly Diagnosed Patients with Multiple Myeloma.

Induction Chemotherapy Followed Immediately by Busulfan-Based Reduced Conditioning and Allografting in Elderly Patients with Advanced MDS or sAML.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only